[Lifelong antipsychotics? A qualitative analysis of questions about phasing out].

Q4 Medicine
Tijdschrift voor psychiatrie Pub Date : 2026-01-01
S Crutzen, J J van Os, S Castelein
{"title":"[Lifelong antipsychotics? A qualitative analysis of questions about phasing out].","authors":"S Crutzen, J J van Os, S Castelein","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Many antipsychotic users at some point want to stop. They mention side effects, functioning and experiencing no benefits.</p><p><strong>Aim: </strong>To explore questions antipsychotic users and their relatives have about stopping or tapering antipsychotics.</p><p><strong>Method: </strong>Data were used from a publicly available anonymous Q&amp;A in which experts answered questions about mental health. Questions about stopping or tapering antipsychotics asked by antipsychotics users and their relatives were analysed using an inductive content analysis.</p><p><strong>Results: </strong>In total 3000 questions were screened, where 426 were about antipsychotics and 194 were about stopping or tapering. The most common question was whether it was sensible to stop. Questions focused on how fast to taper, about the minimum dose, where to find support and when withdrawal symptoms or side effects would subside. Motivations were side effects, difficulties in functioning and experiencing no benefits. Barriers were lack of support and return of symptoms. Facilitators were support from others and experiencing a relief from side effects and/or symptoms.</p><p><strong>Conclusion: </strong>Antipsychotic users and their relatives are left with many questions about stopping. These questions reveal attitudes, preferences and concerns that are important to address when discussing antipsychotic treatment.</p>","PeriodicalId":23100,"journal":{"name":"Tijdschrift voor psychiatrie","volume":"68 2","pages":"64-69"},"PeriodicalIF":0.0000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tijdschrift voor psychiatrie","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Many antipsychotic users at some point want to stop. They mention side effects, functioning and experiencing no benefits.

Aim: To explore questions antipsychotic users and their relatives have about stopping or tapering antipsychotics.

Method: Data were used from a publicly available anonymous Q&A in which experts answered questions about mental health. Questions about stopping or tapering antipsychotics asked by antipsychotics users and their relatives were analysed using an inductive content analysis.

Results: In total 3000 questions were screened, where 426 were about antipsychotics and 194 were about stopping or tapering. The most common question was whether it was sensible to stop. Questions focused on how fast to taper, about the minimum dose, where to find support and when withdrawal symptoms or side effects would subside. Motivations were side effects, difficulties in functioning and experiencing no benefits. Barriers were lack of support and return of symptoms. Facilitators were support from others and experiencing a relief from side effects and/or symptoms.

Conclusion: Antipsychotic users and their relatives are left with many questions about stopping. These questions reveal attitudes, preferences and concerns that are important to address when discussing antipsychotic treatment.

(终身抗精神病药物?关于逐步淘汰问题的定性分析]。
背景:许多抗精神病药物使用者在某些时候想要停止使用。他们提到了副作用,功能和体验没有好处。目的:探讨抗精神病药物服用者及其亲属在停用或减量抗精神病药物方面存在的问题。方法:数据来自一个公开的匿名问答,其中专家回答了有关心理健康的问题。采用归纳内容分析法对抗精神病药物使用者及其亲属关于停药或减量抗精神病药物的问题进行分析。结果:共筛选了3000个问题,其中426个是关于抗精神病药物,194个是关于停药或减量。最常见的问题是,停下来是否明智。问题集中在减药的速度、最低剂量、在哪里寻求支持以及什么时候戒断症状或副作用会消退。动机是副作用,功能障碍,没有任何好处。障碍是缺乏支持和症状复发。引导者是来自他人的支持,并且从副作用和/或症状中得到缓解。结论:抗精神病药物服用者及其家属对停药存在诸多疑问。这些问题揭示了在讨论抗精神病药物治疗时需要解决的重要态度、偏好和关注点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Tijdschrift voor psychiatrie
Tijdschrift voor psychiatrie Medicine-Medicine (all)
CiteScore
0.60
自引率
0.00%
发文量
118
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书